Limosilactobacillus reuteri metabolites modulate immune pathways and intestinal barrier repair after 5 fluorouracil exposure

Abstract Antimetabolites such as 5 fluorouracil are known to induce inflammation in the gut and oral cavity, underscoring the need for strategies that mitigate chemotherapy-associated toxicity. The aim of this study was to determine whether secreted components from the probiotic bacterium Limosilact...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Gintare Lasaviciute, Marta López Plana, Sofia Sundberg Örtegren, Sevasteia Telli, Symeon Kourmoulakis, Ludwig Ermann Lundberg, Kenny Lidberg, Oshadi Peiris, Indranil Sinha, Ann-Beth Jonsson, Stefan Roos, Anna Nilsson, Manuel Mata Forsberg, Eva Sverremark-Ekström
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Nature Portfolio 2026-04-01
Edice:	Scientific Reports
Témata:	Chemotherapy Probiotics Limosilactobacillus reuteri Exopolysaccharides Extracellular membrane vesicles Epithelial cells integrity
On-line přístup:	https://doi.org/10.1038/s41598-026-45524-y
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!